





 

|
Breast Embryology and
Congenital Malformations
Introduction
Embryology, the study of animal development, has been the subject of
scientific curiosity for thousands of years. Some of the earliest recorded
investigations were performed on the chick embryo by the Greek philosopher
Aristotle. The fusion of 2 gametes, the sperm and the egg, is termed
fertilization. The fertilized egg, or zygote, subsequently divides,
differentiates, and maturates into the neonate that is received at birth. This
process is extremely complex but proceeds in a regular, stepwise fashion to
its completion.
The mammary glands are a distinguishing feature of mammals and a primary
symbol of femininity in our culture. Breastfeeding provides nourishment and
passive immunity to offspring, promotes postpartum uterine involution, and
establishes an important bond between mother and infant. The mammary gland
begins development early in embryologic life and only culminates in the
postpartum lactation of the adult female. An understanding of the development
of the mammary gland is essential to anyone asked to evaluate and treat
aberrancies of such development.
Congenital breast malformations can be psychologically debilitating to the
individual. Accurate diagnosis, counseling, and treatment are necessary to
alleviate the sense of deformity and unattractiveness that is often present.
Proper timing of surgical intervention is necessary to optimize functional,
psychological, and aesthetic outcomes. This article describes normal
embryologic mammary gland development and the more common congenital
malformations that may confront the plastic surgeon.
The Integument
The integument consists of 2 layers, the epidermis and dermis, which form a
variety of structures that allow us to interact with our environment. The
epidermis is derived primarily from surface ectoderm but is colonized by
pigment-containing melanocytes of neural crest origin, antigen-processing
Langerhans cells of bone marrow origin, and pressure-sensing Merkel cells of
unclear origin. The dermis is derived primarily from mesoderm and contains
many blood vessels and sensory structures.
During the fourth week of embryologic development, the single cell thick
ectoderm and underlying mesoderm begin to proliferate and differentiate into
the definitive multi-layered skin present at birth. The specialized structures
formed by the skin, including teeth, hair, hair follicles, fingernails,
toenails, sebaceous glands, eccrine glands, apocrine glands, and mammary
glands, also begin to appear at approximately this period in development.
Teeth, hair, and hair follicles are formed by the epidermis and dermis in
concert, while fingernails and toenails are formed by the epidermis alone.
Sebaceous glands, eccrine glands, apocrine glands, and mammary glands are
considered epidermal glands in that they develop as downgrowths or diverticula
of the epidermis into the dermis. Sebaceous glands, or holocrine glands, are
found over the entire surface of the body except the palms, soles, and dorsum
of the feet. They are largest and most concentrated in the face and scalp
where they are the site of origin of acne. The normal function of sebaceous
glands is to produce sebum, a group of complex oils including triglycerides
and fatty acid breakdown products, wax esters, squalene, cholesterol esters,
and cholesterol.
Eccrine sweat glands are found over the entire surface of the body except
the lips, external ear canal, and labia minora. They are most concentrated in
the palms and soles of the feet. The normal function of eccrine glands is to
produce the water and electrolyte component of sweat, which cools the body by
evaporation.
Apocrine sweat glands are similar in structure but not identical to eccrine
glands. They are concentrated in the axillae and anogenital regions. They
probably serve a vestigial sexual function, because they produce odor and do
not function prior to puberty. The mammary gland is considered to be a
modified and highly specialized type of apocrine gland.
The Embryologic Breast
Embryologic development of the mammary gland consists of a series of highly
ordered events involving interactions among a number of distinct cell types.
These interactions are regulated by an array of systemic and local factors
such as growth factors and hormones. Development is initially identical among
males and females of the same species.
During the fourth week of gestation, paired ectodermal thickenings termed
mammary ridges or milk lines develop on the ventral surface of the embryo and
extend in a curvilinear fashion convex towards the midline from the axillae to
the medial thigh. This is the first morphologic evidence of mammary gland
development. In normal human development, these ridges disappear except at the
level of the fourth intercostal space on the anterior thorax, where the
mammary gland subsequently develops. In other species, such as cats and dogs,
multiple paired mammary glands develop along the mammary ridges in the chest,
abdominal, and groin regions. The number of paired glands varies greatly among
mammalian species and is related to the number of offspring in each litter.
During the fifth week of gestation, the remnant of the mammary ridge
ectoderm begins to proliferate and is termed the primary mammary bud. This
primary bud subsequently begins growth downward as a solid diverticulum into
the underlying dermis during the seventh week. By the 10th week, the primary
bud begins to branch, yielding secondary buds by the 12th week, which
eventually develop into the mammary lobules of the adult breast.
This initial downgrowth and subsequent branching has been shown to occur as
the result of an inductive influence of the extracellular matrix of the
mesoderm on the primary mammary bud. This epithelial-mesenchymal signaling is
probably through paracrine and juxtacrine mechanisms where the underlying
mesoderm produces growth factors and hormones that interact with receptors on
the overlying ectodermal cells of the primary mammary bud. The adipose tissue
in the underlying mesoderm represents a significant store of lipids for the
production of hormones and growth factors, which are then available to promote
and regulate growth of the developing mammary gland.
During the remainder of gestation, these buds continue lengthening and
branching. During the 20th week, small lumina develop within the buds that
coalesce and elongate to form the lactiferous ducts. The canalization of the
mammary buds with formation of the lactiferous ducts is induced by placental
hormones entering the fetal circulation. These hormones include progesterone,
growth hormone, insulinlike growth factor, estrogen, prolactin, adrenal
corticoids, and triiodothyronine. At term, approximately 15-20 lobes of
glandular tissue have formed, each containing a lactiferous duct. The
supporting fibrous connective tissue, Cooper ligaments, and fat of the mammary
gland develop from the surrounding mesoderm.
The lactiferous ducts drain into retroareolar ampullae that converge into a
depressed pit in the overlying skin. Each of the 15-20 lobes of the mammary
gland has an ampulla with an orifice opening into this mammary pit. Stimulated
by the inward growth of the ectoderm, the mesoderm surrounding this area
proliferates, creating the nipple with circular and longitudinally oriented
smooth muscle fibers. The surrounding areola is formed by the ectoderm during
the fifth month of gestation. The areola also contains other epidermal glands
including glands of Montgomery, sebaceous glands that serve to lubricate the
areola.
The Neonatal Breast
At birth, the breast is composed of radially arranged mammary lobes
draining via lactiferous ducts into ampullae that empty onto the nipple. These
rudimentary mammary glands are identical in males and females. The nipple
appears as a small pit in the center of a thickened areola containing a few
glands of Montgomery. Shortly after birth, the nipples become everted from
proliferation of the surrounding mesoderm, and the areolae develop a slight
increase in pigmentation. The development of erectile tissue in the nipple
areolar complex causes the nipple to protrude even further upon stimulation.
Failure of the nipples to evert may indicate the presence of inverted
nipples, which is usually caused by fibrous bands and a hypoplastic ductal
system tethering the nipple in the inverted position. This condition is
familial in 50% of patients, may occur in males and females, and is only
clinically significant in that it may present a mechanical problem for women
attempting to breastfeed an infant. The new onset of inverted nipples in
adolescence or adulthood may indicate infection or malignancy.
Falling levels of maternal estrogens in the neonatal bloodstream stimulate
the neonatal pituitary hypophysis to produce prolactin. This results in
unilateral or bilateral breast enlargement in as many as 70% of neonates.
Histologically, this appears as hypertrophy of the ductal system. Acini appear
and an increase in vascularity of the gland is observed. This is often
accompanied by the secretion of witch's milk, a cloudy fluid similar to
colostrum consisting mainly of water, fat, and cellular debris. These changes
occur equally among male and female neonates and regress spontaneously within
several weeks as neonatal prolactin production declines and the glands become
quiescent. However, attempting to strip the breasts of their witch's milk, as
advocated by some superstitions, can lead to a persistent hyperplastic
secretory state lasting many months.
The Male Breast
Embryologic breast development and the transient secretory phase of the
neonatal breast occur in male and female breasts. However, important
developmental differences should be noted. Although the early stages of
development are independent of sex steroid hormones, the mammary glands become
extremely responsive to their hormonal environment. The presence of
testosterone and its binding to mesodermal receptors leads to the normal
involution of the male mammary gland. However, in testicular feminization
syndrome, where circulating testosterone but an absence of testosterone
receptors occurs, the individual develops a female phenotype, including
typical female breast development.
Approximately two thirds of males develop some degree of hyperplasia of the
breasts, or gynecomastia, during puberty. This condition persists for several
months to several years and will spontaneously resolve in all but
approximately 7%. The etiology is usually a decreased ratio of testosterone to
estradiol, and when testicular function becomes dominant, the hypertrophy
resolves. Although temporary in most instances, this condition can be
psychologically devastating to a teenage boy who may be teased by his peers
and, as a result, becomes unwilling to change in gym class or remove his shirt
at the pool or beach.
During this period, the patient or his family may seek consultation and
treatment. Reassurance that the condition is most likely temporary provides
psychological support and hopefully avoids premature surgical intervention.
Use of certain drugs, namely H2 blockers, anabolic steroids, marijuana, and
heroin, can prolong the presence of gynecomastia in this population.
Gynecomastia also is seen in approximately 40% of males with Klinefelter
syndrome (trisomy of the sex chromosomes [XXY]).
Treatment of gynecomastia without underlying cause that does not resolve
spontaneously within several years is relatively simple. Because of the
elasticity of the skin in this population, liposuction alone or a combination
of liposuction with direct subareolar excision techniques is generally
successful. Older patients with less elastic skin may require more standard
breast reduction techniques. Obese patients may benefit from preoperative
weight loss, but still require excision of some sort. Gynecomastia and its
treatment is discussed elsewhere on this website.
Supernumerary breast tissue and the absence of breast tissue also occur in
males and are discussed with other congenital breast malformations in this
article.
The Female Breast
Development of the mammary glands is initiated during embryologic life but
is only complete in the postpartum lactation of the adult female. After the
transient secretion stimulated by prolactin production in the neonate, the
mammary glands, with their relatively simple architecture, remain quiescent
until puberty. During this period, the supporting stromal structures and ducts
enlarge in proportion to the increase in body size of the individual, but no
lobular development occurs.
Thelarche, the rapid growth that occurs at the onset of puberty, is
primarily from deposition of fat and development of periductal connective
tissue, but elongation and thickening of the ductal system also occurs at this
stage. Ductal growth occurs under the influence of circulating estrogens,
growth hormone, and prolactin but is independent of progesterone. The
development initiated at the onset of puberty is generally complete by age 20
years.
If pregnancy occurs, the glands complete their differentiation and reach
functional maturity with the intralobular-branched ducts forming buds that
become secretory alveoli. This occurs under the influence of sustained
increases in the levels of circulating progesterone, estrogens, prolactin, and
placental lactogen. The epithelial cells of the alveoli begin to accumulate
the cytoplasmic organelles necessary to sustain lactation in the postpartum
period.
Following parturition, lactation proceeds as a response to environmental
stimuli and the withdrawal of circulating progesterone. Prolactin, originating
in the anterior pituitary, and somatomammotropin, originating in the placenta,
stimulate the alveolar epithelium to produce and secrete milk proteins,
primarily casein and alpha-lactalbumin, and lipids. In response to suckling or
crying, oxytocin produced by the hypothalamus but released by the posterior
pituitary causes contraction of myoepithelial cells surrounding the alveoli,
which expels the milk to assist the suckling child.
With cessation of nursing, milk production also ceases because of a
decrease in circulating prolactin and the inhibitory effects of nonexpelled
milk. The alveoli then return to their prior nonfunctioning state. By age 40
years, the mammary glands begin to atrophy. During and after menopause, the
altered hormonal environment leads to a senescent state, with involution of
the glandular component and replacement with connective tissue and fat.
Congenital Breast Malformations
Congenital breast malformations range in severity from the relatively minor
to major chest wall deformities. Minor malformations may not even be
recognized, while major deformities may cause significant functional,
psychological, and aesthetic concerns. The affected individual may present for
consultation at any age, often early in childhood as a result of parental
concern. It is important to be able to counsel the patient and his or her
family regarding the nature of the problem, its prognosis for future
development, and the appropriate indications and timing of surgical
intervention. These malformations generally fall into 1of 2 categories, the
presence of supernumerary breast tissue or the absence or underdevelopment of
breast tissue.
The presence of supernumerary breast tissue indicates incomplete involution
of the milk line, resulting in the formation of accessory mammary tissue from
the redundant clusters of ectopic primordial breast cells. This occurs in 2-6%
of females and 1-3% of males. Approximately one third of affected individuals
have more than one site of supernumerary breast tissue development. Most of
this accessory breast tissue has no physiologic significance, but some may
enlarge with the onset of puberty, pregnancy, or lactation, and can be the
site of breast carcinoma.
Approximately 67% of accessory breast tissue occurs in the thoracic or
abdominal portions of the milk line, often just below the inframammary crease
and more often on the left side of the body. Another 20% occurs in the axilla.
The remaining locations include anywhere along the milk line or in the
buttock, back, face, and neck. Supernumerary tissue present in any location
other than along the milk line represents a migratory arrest of breast
primordium during chest wall development.
In 1915, Kajava published a classification system for supernumerary breast
tissue that remains in use today. Class I consists of a complete breast with
nipple, areola, and glandular tissue. Class II consists of nipple and
glandular tissue but no areola. Class III consists of areola and glandular
tissue but no nipple. Class IV consists of glandular tissue only. Class V
consists of nipple and areola but no glandular tissue (pseudomamma). Class VI
consists of a nipple only (polythelia). Class VII consists of an areola only (polythelia
areolaris). Class VIII consists of a patch of hair only (polythelia pilosa).
The most common form of supernumerary breast tissue is polythelia, the
presence of more than 2 nipples on an individual. More than 90% of
supernumerary nipples occur in the inframammary region. This condition is
present in 2-5% of the general population, although many additional patients
may go undiagnosed because the nipple is often confused for a nevus or other
benign skin lesion because of its diminutive size. Males and females have an
overall equal incidence, but differences are observed within ethnic groups.
For example, polythelia is present in 5% of Japanese females but only 1.6% of
Japanese males. Differences also exist among ethnic groups. Polythelia occurs
less frequently in Caucasians (0.6%) than in blacks (3.5%). Most cases are
sporadic, but approximately 6% are familial and are believed to represent an
autosomal dominant trait with variable penetrance.
The image below was a supernumerary nipple found just beneath the
inframammary crease of the right breast of a young woman. This was removed for
cosmetic reasons.

A correlation exists between renal disease and polythelia. Nephrologic
abnormalities such as cysts, duplications, or unilateral renal agenesis have
been found in 14.5% of sporadic cases and 32.1% of familial cases compared to
1-2% of the general population. Approximately 19% of patients with renal
adenocarcinoma have polythelia, and 16.5% of patients with end-stage renal
disease have polythelia. Considering the significant incidence of congenital
and acquired renal disorders in patients with polythelia, patients should be
aware of the need for regular physical examination and urinalysis. Any
abnormality noted should alert the physician to the need for a renal
ultrasound.
Polymastia, the presence of accessory glandular tissue, is the second most
common form of supernumerary breast tissue, occurring in 1-2% of the female
population. Various forms exist, as described by Kajava Classes I through IV,
but most commonly the nipple and areola are absent or rudimentary. The most
common location is in the axilla, where they may present as axillary fullness
responsive to hormonal cycles of menstruation, pregnancy, or lactation. The
second most common location is in the inframammary region, similar to
polythelia. Most cases are sporadic, but this condition also has been observed
as a heritable trait.
The presence of supernumerary tissue can be psychologically disturbing to
adolescents. Excision is recommended prior to puberty or at any age when the
condition is recognized and becomes of concern to the individual.
The absence or underdevelopment of breast tissue is less common than the
presence of supernumerary tissue. These conditions may be unilateral or
bilateral and result from partial or complete underdevelopment of the mammary
bud. The most severe form is amastia, the complete absence of glandular
tissue, nipple, and areola. Hypoplasia, the presence of very small rudimentary
breasts, is the most common form. Amastia and hypoplasia may be associated
with scalp defects, ear abnormalities, renal hypoplasia, and cataracts in
patients with the rare autosomal dominant Finlay-Marks syndrome. Hypoplasia
also may occur in patients with Turner syndrome (ovarian agenesis), congenital
adrenal hyperplasia, and delayed menarche where the administration of oral
estrogen therapy usually promotes glandular development.
Aplasia, the absence of glandular tissue in the presence of a nipple and
areola, is most commonly encountered in Poland syndrome, first described in
1841. This condition is often accompanied by musculoskeletal deformities of
the chest wall and ipsilateral upper extremity and is discussed in a separate
article. Athelia, absence of the nipple and areola in the presence of
glandular tissue, is the most rare of these conditions. It is infrequently
seen as an isolated defect except in ectodermal dysplasia syndromes.
The goal of surgical therapy in these patients is to achieve breast
symmetry. This may best be performed in late adolescence when the
contralateral breast has reached its mature size and shape. However, earlier
intervention may be indicated in the patient with a significant sense of
deformity that is adversely affecting body image. Techniques to achieve
symmetry may include prosthetic devices such as implants or expanders,
autologous tissue such as the latissimus dorsi or rectus abdominis muscles, or
both.
Conclusion
The mammary gland is a complex organ that begins development early in
gestation. The extensive research currently being performed on the human
genome, molecular biology, and growth factors will certainly contribute to the
further elucidation of the embryologic factors involved in the formation,
differentiation, and development of the mammary gland. This may provide
important insights into the cause, treatment, and potential prevention of
mammary gland abnormalities, such as congenital malformations and breast
cancer. Given that breast cancer strikes 10% of women in the US and congenital
malformations occur in 2-6%, these developments may have enormous implications
for the future of medicine.
Bibliography
- Carlson BM: Integumentary, skeletal, and muscular systems. Human
Embryology and Developmental Biology 1994; 1st edition: 153-181.
- Casey HD, Chasan PE, Chick LR: Familial polythelia without
associated abnormalities. Ann Plast Surg 1996; 36: 101-104.
- Denk MJ: Topics in pediatric plastic surgery. Pediatr Clin North Am
1998; 45(6): 1479-1506.
- Forsyth IA: The mammary gland. Baillieres Clin Endocrinol Metab
1991; 5(4): 809-832.
- Georgiade NG, Georgiade GS, Riefkohl R: Esthetic breast surgery.
Plastic Surgery 1990; 5: 3839-3896.
- Gilbert SF: Cell interactions at a distance: hormones as mediators
of development. Developmental Biology 1997; 5th edition: 733-772.
- Hovey RC, McFadden TB, Akers RM: Regulation of mammary gland growth
and morphogenesis by the mammary fat pad:a species comparison. J Mammary
Gland Biol Neoplasia 1999; 4(1): 53-68.
- Kajava Y: The proportions of supernumerary nipples in the Finnish
population. Duodecim 1915; 31: 143-170.
- Kamalati T, Niranjan B, Yant J et al: HGF/SF in mammary epithelial
growth and morphogenesis:in vitro and in vivo models. J Mammary Gland Biol
Neoplasia 1999; 4(1): 69-77.
- McCarty KS Jr, Carpenter SA, Georgiade GS: The breast: embryology,
anatomy, and physiology. Aesthetic Surgery of the Breast 1990; 1st
edition: 3-18.
- Medina D: The mammary gland: a unique organ for the study of
development and tumorigenesis. J Mamm Gland Biol Neoplasia 1996; 1(1):
5-19.
- Moore, KL, Persuad, TVN: The integumentary system. Before We Are
Born: Essentials of Embryology and Birth Defects 1998; 5th edition:
481-496.
- Plessis G, Le Treust M, Le Merrer M: Scalp defect, absence of
nipples, ear anomalies, renal hypoplasia:another case of Finlay-Marks
syndrome. Clin Genet 1997; 52: 231-234.
- Robinson GW, Karpf AB, Kratochwil K: Regulation of mammary gland
development by tissue interaction. J Mammary Gland Biol Neoplasia 1999;
4(1): 9-19.
- Romrell LJ, Bland KI: Anatomy of the breast, axilla, chest wall, and
related metastatic sites. The Breast: Comprehensive Management of Benign
and Malignant Diseases 1991; 1st edition: 17-35.
- Rush BF Jr: Breast. Principles of Surgery 1989; 5th edition:
549-580.
- Salomon, DS, Bianco C, De Santis, M: Cripto:a novel epidermal growth
factor (EGF)-related peptide in mammary gland development and neoplasia.
BioEssays 1999; 21: 61-70.
- Urbani CE, Betti R: Sporadic unilateral intra-areolar polythelia.
Acta Derm Venereol 1995; 76: 156.
- Walden PD, Ruan W, Feldman M et al: Evidence that the mammary fat
pad mediates the action of growth hormone in mammary gland development.
Endocrinology 1998; 139(2): 659-662.
For more information, please call our office for a complimentary consultation
(954-630-2009), or you may email Dr. Revis at the address below.
Email: DrRevis@SouthFloridaPlasticSurgery.com
|